UPDATED: Novartis CEO Vas Narasimhan restructures the pharma giant, cutting costs $1B+, ousting top execs and signaling layoffs ahead - Endpoints News
4/4/2022 12:00:00 AM3 years 1 month ago
by John Carroll
by John Carroll
Novartis CEO Vas Narasimhan has a plan to make the global pharma giant more profitable. And he’s starting by carving out a billion dollars-plus in costs in a move that signals job cuts from the top team on down. The centerpiece in this restructuring involves …
With the rise of the Omicron sister variant BA.2, GlaxoSmithKline and Vir Biotechnology’s crucial monoclonal antibody — one of only two mAbs still being shipped by the US government to states to trea… [+587 chars]
full article...